Labcorp Holdings Files 8-K on Definitive Agreement

TL;DR

Labcorp just filed an 8-K for a material definitive agreement and financial obligation. Big moves ahead.

AI Summary

On January 31, 2025, LABCORP HOLDINGS INC. filed an 8-K report detailing a material definitive agreement and the creation of a direct financial obligation. The filing also included financial statements and exhibits.

Why It Matters

This filing indicates Labcorp Holdings Inc. has entered into a significant agreement that may impact its financial obligations and operations.

Risk Assessment

Risk Level: medium — The filing concerns a material definitive agreement and financial obligations, which inherently carry financial and operational risks.

Key Numbers

• 1-11353 — SEC File Number (Identifies the specific SEC filing for Labcorp Holdings Inc.)
• 99-2588107 — IRS Employer Identification No. (Tax identification number for Labcorp Holdings Inc.)

Key Players & Entities

• LABCORP HOLDINGS INC. (company) — Registrant
• January 31, 2025 (date) — Filing Date
• 0000920148-25-000017 (document_id) — Accession Number

FAQ

Key Financial Figures

• $0.10 — ange on which registered Common Stock, $0.10 par value LH New York Stock Exchange
• $300 million — ) the facility limit was increased from $300 million to $700 million, (ii) The Toronto-Domin
• $700 m — imit was increased from $300 million to $700 million, (ii) The Toronto-Dominion Bank w

Filing Documents

• lh-20250131.htm (8-K) — 29KB
• exhibit101firstamendmentto.htm (EX-10.1) — 1623KB
• 0000920148-25-000017.txt ( ) — 2020KB
• lh-20250131.xsd (EX-101.SCH) — 2KB
• lh-20250131_lab.xml (EX-101.LAB) — 22KB
• lh-20250131_pre.xml (EX-101.PRE) — 12KB
• lh-20250131_htm.xml (XML) — 3KB

01 Entry into a Material Definitive Agreement

Item 1.01 Entry into a Material Definitive Agreement. On January 31, 2025, Labcorp Holdings Inc. (the "Company") amended its receivables purchase agreement (as amended, the "Receivables Purchase Agreement") by entering into the First Amendment to the Receivables Purchase Agreement (the "RPA Amendment"), among Labcorp Receivables LLC ("Labcorp Receivables"), Laboratory Corporation of America Holdings, PNC Bank, National Association, as administrative agent and the other parties party thereto and acknowledged and agreed by the Company. Pursuant to the RPA Amendment, among other things, (i) the facility limit was increased from $300 million to $700 million, (ii) The Toronto-Dominion Bank was joined to the Receivables Purchase Agreement as a committed purchaser with a scheduled commitment termination date of January 30, 2026 (for the avoidance of doubt, no change was made to the scheduled commitment termination date of August 23, 2027 for all other committed purchasers) and (iii) MUFG Bank Ltd. and certain of its related conduit purchasers (the "Related MUFG Conduit Purchasers") were joined to the Receivables Purchase Agreement as purchasers and the loans or investments of such Related MUFG Conduit Purchasers may accrue interest at a rate equal to the CP Rate (as defined in the Receivables Purchase Agreement) plus an applicable margin (for the avoidance of doubt, no change was made to the interest rate of all other purchasers which is equal to a daily SOFR rate or term SOFR rate plus 0.10% SOFR adjustment or a base rate, in each case, plus an applicable margin ). Labcorp Receivables is a separate legal entity with its own separate creditors who will be entitled to access Labcorp Receivables assets before the assets become available to the Company. Accordingly, Labcorp Receivables assets are not available to pay creditors of the Company or any of its subsidiaries (other than Labcorp Receivables), although collections from the receivables in excess of amounts required

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. Exhibit Exhibit Name Exhibit 10.1 First Amendment to Receivables Purchase Agreement dated as of January 31, 2025 Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LABCORP HOLDINGS INC. Registrant Date: January 31, 2025 By: /s/ SANDRA VAN DER VAART Sandra van der Vaart Executive Vice President, Chief Legal Officer and Corporate Secretary

View Full Filing

View this 8-K filing on SEC EDGAR